Lilian C. Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lilian C. Wang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Averi E. Kitsch
1 shared publication- Basak Erguvan Dogan
The University of Texas Southwestern Medical Center
1 shared publication - Bonnie N. Joe
Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94158, USA
1 shared publication Christopher E. Comstock
1 shared publication- Colleen H. Neal
Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan; Division of Breast Imaging, University of Michigan Health System, Ann Arbor, Michigan
1 shared publication - Dariya Malyarenko
Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA
1 shared publication
Latest Publications
- Open Access
- 13 May 2023
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 5 (5) , 597-610
Reducing False Negatives in Biopsy of Suspicious MRI Findings
Breast MRI is a highly sensitive imaging modality that often detects findings that are occult on mammography and US. Given the overlap in appearance of benign and malignant lesions, an accurate method of tissue sampling for MRI-detected findings is essential. Although MRI-directed US and correlation with mammography can be helpful for some lesions, a correlate is not always found. MRI-guided biopsy is a safe and effective method of tissue sampling for findings seen only on MRI. The unique limitations of this technique, however, contribute to false negatives, which can result in delays in diagnosis and adverse patient outcomes; this is of particular importance as most MRI examinations are performed in the high-risk or preoperative setting. Here, we review strategies to minimize false negatives in biopsy of suspicious MRI findings, including appropriate selection of biopsy modality, use of meticulous MRI-guided biopsy technique, management after target nonvisualization, assessment of adequate lesion sampling, and determination of radiology-pathology concordance. A proposed management algorithm for MRI-guided biopsy results will also be discussed.
- 13 May 2023
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 5 (5) , 597-610
Open AccessReducing False Negatives in Biopsy of Suspicious MRI Findings
Breast MRI is a highly sensitive imaging modality that often detects findings that are occult on mammography and US. Given the overlap in appearance of benign and malignant lesions, an accurate method of tissue sampling for MRI-detected findings is essential. Although MRI-directed US and correlation with mammography can be helpful for some lesions, a correlate is not always found. MRI-guided biopsy is a safe and effective method of tissue sampling for findings seen only on MRI. The unique limitations of this technique, however, contribute to false negatives, which can result in delays in diagnosis and adverse patient outcomes; this is of particular importance as most MRI examinations are performed in the high-risk or preoperative setting. Here, we review strategies to minimize false negatives in biopsy of suspicious MRI findings, including appropriate selection of biopsy modality, use of meticulous MRI-guided biopsy technique, management after target nonvisualization, assessment of adequate lesion sampling, and determination of radiology-pathology concordance. A proposed management algorithm for MRI-guided biopsy results will also be discussed.
- 14 February 2022
- Published by Elsevier in Academic Radiology
- Vol. 29 (5) , 648-649
Skin Changes in Inflammatory Breast Cancer: Role of MRI in Evaluation of Treatment Response
- 14 February 2022
- Published by Elsevier in Academic Radiology
- Vol. 29 (5) , 648-649
Skin Changes in Inflammatory Breast Cancer: Role of MRI in Evaluation of Treatment Response
- 17 November 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 298 (1) , 60-70
Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial
An approach for measuring mean apparent diffusion coefficient that used two b values is sufficient for improving diagnostic performance of breast MRI and reducing the biopsy rate by up to 22.4% wit... Background The Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Cancer Research Group A6702 multicenter trial helped confirm the potential of diffusion-weighted ...
- 17 November 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 298 (1) , 60-70
Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial
An approach for measuring mean apparent diffusion coefficient that used two b values is sufficient for improving diagnostic performance of breast MRI and reducing the biopsy rate by up to 22.4% wit... Background The Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Cancer Research Group A6702 multicenter trial helped confirm the potential of diffusion-weighted ...
- 1 May 2017
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 55 (3) , 553-577
MR Imaging
- 1 May 2017
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 55 (3) , 553-577
MR Imaging